PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 30.209
AS - Asia 8.460
EU - Europa 8.400
SA - Sud America 1.220
AF - Africa 133
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 21
Totale 48.566
Nazione #
US - Stati Uniti d'America 30.020
SG - Singapore 3.417
CN - Cina 2.888
UA - Ucraina 1.830
IT - Italia 1.699
DE - Germania 1.488
BR - Brasile 1.102
TR - Turchia 1.048
GB - Regno Unito 873
FI - Finlandia 685
NL - Olanda 585
SE - Svezia 486
ID - Indonesia 352
HK - Hong Kong 181
PL - Polonia 180
FR - Francia 138
CA - Canada 115
AU - Australia 107
VN - Vietnam 103
IN - India 102
AT - Austria 89
BE - Belgio 53
ZA - Sudafrica 51
CZ - Repubblica Ceca 46
IQ - Iraq 46
JP - Giappone 43
MX - Messico 43
RU - Federazione Russa 43
TW - Taiwan 42
AR - Argentina 34
BD - Bangladesh 33
ES - Italia 33
LT - Lituania 33
PK - Pakistan 32
KR - Corea 25
CH - Svizzera 23
IE - Irlanda 23
EG - Egitto 22
CO - Colombia 19
IR - Iran 18
MA - Marocco 17
VE - Venezuela 17
EC - Ecuador 16
KE - Kenya 16
NZ - Nuova Zelanda 16
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 14
EU - Europa 13
GR - Grecia 13
PE - Perù 13
PH - Filippine 13
SA - Arabia Saudita 12
PT - Portogallo 11
RO - Romania 10
TH - Thailandia 10
HU - Ungheria 9
MY - Malesia 9
TN - Tunisia 9
HR - Croazia 8
VI - Stati Uniti Isole Vergini 8
AL - Albania 7
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
RS - Serbia 7
AZ - Azerbaigian 6
MK - Macedonia 6
PY - Paraguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
BO - Bolivia 5
CL - Cile 5
JM - Giamaica 5
PA - Panama 5
BY - Bielorussia 4
DZ - Algeria 4
GE - Georgia 4
JO - Giordania 4
LV - Lettonia 4
NG - Nigeria 4
PS - Palestinian Territory 4
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
ZW - Zimbabwe 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
LK - Sri Lanka 2
MG - Madagascar 2
MU - Mauritius 2
MZ - Mozambico 2
NO - Norvegia 2
YE - Yemen 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 48.551
Città #
Fairfield 4.047
Woodbridge 3.629
Houston 2.611
Jacksonville 2.033
Ashburn 1.938
Chandler 1.621
Santa Clara 1.517
Seattle 1.495
Wilmington 1.427
Singapore 1.420
Ann Arbor 1.327
Cambridge 1.317
Izmir 700
Beijing 657
Nanjing 633
Princeton 564
San Diego 367
Ferrara 332
Jakarta 331
Munich 318
Boardman 285
Los Angeles 251
Milan 241
Washington 233
Nanchang 192
New York 189
Shanghai 174
Warsaw 170
Shenyang 169
Hong Kong 163
Helsinki 155
Addison 131
Tianjin 125
Hebei 124
London 116
Dearborn 108
Changsha 103
Jiaxing 100
Chicago 93
Dong Ket 90
Mountain View 86
Lappeenranta 83
Falls Church 79
Nuremberg 78
Redwood City 74
Rome 74
São Paulo 72
Turku 68
Norwalk 66
Zhengzhou 65
The Dalles 53
Jinan 50
Kunming 50
Bremen 49
Brussels 46
Ningbo 46
Orange 46
Falkenstein 44
Vienna 44
Guangzhou 43
Toronto 42
Verona 42
Bologna 41
Council Bluffs 39
Frankfurt am Main 38
San Mateo 36
Auburn Hills 31
Rio de Janeiro 31
Taizhou 31
Brno 29
Paris 28
Tokyo 28
Dallas 27
Des Moines 27
Lanzhou 27
San Francisco 27
Belo Horizonte 25
Beauharnois 24
Brooklyn 24
Philadelphia 24
Sydney 24
Naples 23
Parma 20
Boston 19
Changchun 19
Hangzhou 19
Tappahannock 18
Curitiba 17
Melbourne 17
Atlanta 16
Brisbane 16
Florence 16
Goiânia 16
Istanbul 16
Olomouc 16
Perth 16
Baghdad 15
Campinas 15
Indiana 15
Johannesburg 15
Totale 33.681
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 587
Asthma 429
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 338
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 278
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 277
Targeting Th2 cells in asthmatic airways 242
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 237
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 194
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 191
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 188
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 185
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 182
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 168
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 163
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 163
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 160
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 159
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 158
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 158
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 157
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 156
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 155
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 154
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 153
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 151
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 150
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 150
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 148
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 148
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 147
Malattie polmonari primitive da cause dismetaboliche. 147
Models of infection and exacerbations in COPD. 145
COPD: early diagnosis and treatment to slow disease progression 145
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 143
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 143
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 142
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 142
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis. 142
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 141
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 141
Rhinovirus vaccination: the case against 140
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 140
Management of bronchial asthma 139
INSTEAD: A randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD 138
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 135
Combination treatment in asthma: Reviewing old and new options 135
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 135
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 135
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 133
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 133
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 131
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 131
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 131
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 131
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 131
Mechanisms of rhinovirus-induced asthma. 131
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 130
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 130
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 129
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 129
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 128
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 128
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 128
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 128
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 127
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 126
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 126
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 125
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 125
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 125
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma 125
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. 125
A defective type 1 response to rhinovirus in atopic asthma 124
Chronic obstructive pulmonary disease international guidelines. 124
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 123
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 123
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 123
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 123
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 122
Protection of erdosteine on smoke‐induced peripheral neutrophil dysfunction both in healthy and in bronchitic smokers 121
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 121
COPD exacerbations: definitions and classifications 121
null 121
Severe asthma: Phenotyping to endotyping or vice versa? 121
Enfisema polmonare: prospettive di terapia 120
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 120
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 120
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 119
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 119
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 119
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 118
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients 118
null 118
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 118
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 118
Management of patients with early mild asthma and infrequent symptoms 118
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 118
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting 118
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 117
Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school children 117
Totale 15.102
Categoria #
all - tutte 274.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.880
Totale 287.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 0 0 0 0 0 196
2020/20216.478 437 479 305 731 321 681 279 751 170 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.198 574 101 145 487 619 641 179 384 529 65 313 161
2023/20242.739 248 266 112 83 137 279 78 136 88 259 348 705
2024/202510.975 303 293 996 330 1.305 812 351 715 1.932 1.649 1.443 846
Totale 49.748